China Resources Pharmaceutical Group Limited (HKG:3320)
4.510
+0.010 (0.22%)
Jan 21, 2026, 10:24 AM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 28.33 billion as of January 20, 2026. Its market cap has decreased by -20.32% in one year.
Market Cap
28.33B
Enterprise Value
152.77B
Revenue
285.94B
Ranking
n/a
PE Ratio
9.24
Stock Price
4.51
Market Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 28.33B, a decrease of -49.05%. That is a compound annual growth rate of -7.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 28.33B | 1.35% |
| Dec 31, 2025 | 27.96B | -21.93% |
| Dec 31, 2024 | 35.81B | 11.11% |
| Dec 29, 2023 | 32.23B | -18.83% |
| Dec 30, 2022 | 39.71B | 78.03% |
| Dec 31, 2021 | 22.30B | -10.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |